Dr. Brian McNeel
Optometrist/Owner
Dr. Brian J. McNeel is the Founder and Owner of McNeel Eye Center. He received his Bachelor's degree from The College of Idaho in 1988. Following graduation, he spent three years conducting research in immunology at the University of Washington in Seattle. In fact, several discoveries made in Dr. McNeel's laboratory are still used internationally in cancer research.
Dr. Brian J. McNeel is the Founder and Owner of McNeel Eye Center. He received his Bachelor's degree from The College of Idaho in 1988. Following graduation, he spent three years conducting research in immunology at the University of Washington in Seattle. In fact, several discoveries made in Dr. McNeel's laboratory are still used internationally in cancer research.
Dr. McNeel graduated at the top of his class from the Southern California of Optometry in 1995. He joined the staff of The Eye Institute of Utah in 1997, and Hollingshead Eye Center in Boise shortly thereafter. Following 12 years of practice he decided to relocate his office to Eagle Road to be nearer his home and family.
A fellow of the American Academy of Optometry, Dr. McNeel is board-certified in the treatment and management of ocular disease. Additionally, he held a faculty appointment at The Ohio State University's College of Optometry as an adjunct clinical instructor. An accomplished lecturer, Dr. McNeel teaches continuing medical education to optometrists in many states.
Dr. McNeel is one of Idaho's most experienced providers of LASIK and cataract aftercare, with well over 30,000 office visits related to these and other surgeries.
He is available for comprehensive and medical eye examinations, contact lens fitting, and advanced dry eye disease, and he offers consultations to patients of all ages.
Dr. McNeel is currently conducting a clinical trial utilizing a gentle epithelium-on approach to treating Keratoconus with corneal crosslinking. This novel approach to managing Keratoconus is unique to Dr. McNeel and he is one of two people in Idaho treating this sight-threatening disease with this new method.
